Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
27 Febbraio 2024 - 10:05PM
Business Wire
Phreesia is proud to announce that its Chief Clinical Officer
Hilary Hatch, PhD, has been selected to participate in the National
Quality Forum (NQF)’s 2024-2025 Leadership Consortium. Dr. Hatch is
one of only 29 healthcare leaders included in the prestigious
group, underscoring her dedication to healthcare quality and
patient-centered care. She was first named to the group for a
two-year term in 2022.
NQF’s Leadership Consortium is an exclusive forum of experts
representing public and private sector NQF Member Organizations, in
which leaders prioritize a key area of need in healthcare quality
and share their expertise to guide actionable recommendations for
positive change. These recommendations are tested in real-world
settings and the results are shared widely with healthcare
organizations to scale implementation and solutions throughout the
healthcare ecosystem.
“At Phreesia, we believe that when people become active
participants in their care, we will see optimal health and
healthcare outcomes,” said Dr. Hatch. “I’m honored to be part of
this esteemed group for the second time and look forward to
bringing the focus on the patient voice to our collective efforts
to advance health equity and quality.”
Dr. Hatch, a clinical psychologist, leads the development of
clinical programs and research partnerships at Phreesia. She
partners with organizations to help patients become more active
participants in their care, which improves health outcomes. She
also leads efforts to support the implementation of
patient-reported outcome measures, screenings for social drivers of
health and behavioral health, and other tools to close gaps in
care. Dr. Hatch is a champion of the Patient Activation Measure®
(PAM ®), which measures a patient’s knowledge, skills and
confidence to self-manage their health. PAM is successfully used as
a performance measure, which has been endorsed by the NQF and was
also recently included in the Centers for Medicare and Medicaid
Services Merit-Based Incentive Payment System.
“The topics we will consider are some of the most critical
challenges in healthcare today. Being able to identify effective
strategies for addressing any one of them could have a big impact,”
said Shawn Griffin, MD, FAAFP, President and CEO, URAC, one of the
group’s two Co-Chairs. “Participation in the Leadership Consortium
is more than just an honor for us as individuals or for the
organizations we represent. It is a chance to advance real progress
on an important aspect of healthcare quality.”
The 2024-2025 Consortium members will consider five current
healthcare issues from which to choose a key priority area,
including addressing youth mental health and suicidality, improving
postpartum care quality, reducing implicit bias to provide
affirming care, supporting safe medication administration practices
and sustaining workforce capacity and training.
For more information on Phreesia, visit www.phreesia.com.
About Phreesia
Phreesia is the trusted leader in patient activation, giving
providers, health plans, life sciences companies and other
organizations tools to help patients take a more active role in
their care. Founded in 2005, Phreesia enabled more than 120 million
patient visits in 2022–more than 1 in 10 visits across the
U.S.–scale that we believe allows us to make meaningful impact.
Offering patient-driven digital solutions for intake, outreach,
education and more, Phreesia enhances the patient experience,
drives efficiency and improves healthcare outcomes. To learn more,
visit www.phreesia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227815115/en/
Media Nicole Gist Nicole.Gist@phreesia.com
407-760-6274
Grafico Azioni Phreesia (NYSE:PHR)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Phreesia (NYSE:PHR)
Storico
Da Giu 2023 a Giu 2024